Immunotherapy for Early-Stage Non–Small Cell Lung Cancer: A Practical Guide of Current Controversies
Clinical Lung Cancer · 2025-05 · 26 (3) · 179-190
DOI: 10.1016/j.cllc.2025.01.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Lung Cancer, 2025-05. Verfasst von William J Phillips und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunotherapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The role of immunotherapy as systemic therapy for nonmetastatic non-small cell lung cancer (NSCLC) has evolved rapidly over the last decade. There are several well-conducted phase 3 clinical trials evaluating immunotherapy in the neoadjuvant, perioperative, adjuvant and nonoperative setting. In this narrative review, we summarize the data from these studies and discuss ongoing controversies in applying these data to clinical practice. These controversies relate to the value of the adjuvant component of perioperative immunotherapy, treatment of patients with PDL1 negative tumors, defining resectability, optimal use of operative versus nonoperative management, the role of stereotactic radiation therapy for very early lung cancers, and management of tumors with an oncogenic driver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Department of Surgery and Cancer Care Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
- Division of Radiation Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: pwheatleyprice@toh.ca.
Zitieren
APA
Phillips, W. J., Jackson, A., Kidane, B., Lim, G., Navani, V., & Wheatley-Price, P. (2025). Immunotherapy for Early-Stage Non–Small Cell Lung Cancer: A Practical Guide of Current Controversies. Clinical Lung Cancer, 26(3), 179-190. https://doi.org/10.1016/j.cllc.2025.01.006
Vancouver
Phillips WJ, Jackson A, Kidane B, Lim G, Navani V, Wheatley-Price P. Immunotherapy for Early-Stage Non–Small Cell Lung Cancer: A Practical Guide of Current Controversies. Clinical Lung Cancer. 2025;26(3):179-190. doi:10.1016/j.cllc.2025.01.006
BibTeX
@article{Phillips2025,
author = {Phillips, William J and Jackson, Ashley and Kidane, Biniam and Lim, Gerald and Navani, Vishal and Wheatley-Price, Paul},
title = {Immunotherapy for Early-Stage Non–Small Cell Lung Cancer: A Practical Guide of Current Controversies},
journal = {Clinical Lung Cancer},
year = {2025},
volume = {26},
number = {3},
pages = {179--190},
doi = {10.1016/j.cllc.2025.01.006}
}
EUVIMED